Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial

Design, participants, setting, and measurements: Predialysis adult participants with chronic kidney disease (CKD) and mean estimated glomerular filtration rate (eGFR) <45 mL/min per 1.73 m(2)) were recruited in 2019 to a multicentric double-blinded randomized controlled trial of enzobiotic therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Anita, Srinivasa, Sanjay, Veerappan, Ilangovan, Jacob, Chakko, Mahaldar, Amol, Gupta, Amit, Rajagopal, Ananthasubramaniam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503043/
https://www.ncbi.nlm.nih.gov/pubmed/36145188
http://dx.doi.org/10.3390/nu14183804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503043/
https://www.ncbi.nlm.nih.gov/pubmed/36145188
http://dx.doi.org/10.3390/nu14183804

Ejemplares similares